top of page
Search
Kasia Goljanek-Whysall

Clinical trial of senolytics in humans

https://www.ncbi.nlm.nih.gov/pubmed/?term=Senolytics+in+idiopathic+pulmonary+fibrosis%3A+Results+from+a+first-in-human%2C+open-label%2C+pilot+study


Selectively ablating senescent cells using dasatinib and quercetin alleviates Idiopathic Pulmonary Fibrosis-related dysfunction in mice; this article explores the effects of dasatinib and quercetin in humans.

4 views0 comments

Recent Posts

See All

Comments


Post: Blog2_Post
bottom of page